We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > immunotherapy

News List

Cue Biopharma in $374M-plus Merck immunotherapy pact fiercebiotech
November 17, 2017
After raising $26 million at the start of the year, cancer and autoimmune startup Cue Biopharma has ended the year with a potentially lucrative new deal with Merck.
NIH launches $215m partnership for cancer immunotherapy strategies europeanpharmaceuticalreview
October 16, 2017
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot….
Boosting immunotherapy by targeting cells’ recycling centers fiercebiotech
August 29, 2017
Memory T cells can be boosted with a drug normally used to prevent transplanted organs from being rejected, UCSD researchers found.
Myeloma UK launches ‘world first’ immunotherapy trial pharmatimes
March 20, 2017
Myeloma UK has launched a ground-breaking immunotherapy trial which aims to modulate the immune system to target myeloma.